Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04759781
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-08
First Post:
2021-02-15
Brief Title:
MElanoma Research Lymph Node Prediction Implementation National_001
Sponsor:
SkylineDx
Organization:
SkylineDx
Study Overview
Official Title:
A Prospective Registry Study of a Primary Melanoma Gene-signature to Predict Sentinel Node SN Status and Determine Its Prognostic Value for More Accurate Staging of SN-negative Melanoma Patients
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MERLIN_001
Brief Summary:
MERLIN_001 is a prospective registry study of a primary melanoma gene-signature to predict sentinel node SN status and to determine its prognostic value for more accurate staging of SN-negative melanoma patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None